CHERI CARTAGENA: Open Payments
NPI 1538310230 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,028 in 137 payments from 20 companies in 2025. Trend: 2023 $4,046 · 2024 $2,299 · 2025 $3,028
Food & beverage: $2,927Education: $101
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $570 |
| ABBVIE INC. | 27 | $483 |
| PFIZER INC. | 17 | $353 |
| Novartis Pharmaceuticals Corporation | 17 | $344 |
| UCB, Inc. | 7 | $200 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $180 |
| Regeneron Healthcare Solutions, Inc. | 10 | $170 |
| Galderma Laboratories, L.P. | 9 | $139 |
| GENZYME CORPORATION | 1 | $125 |
| Incyte Corporation | 5 | $98 |
Products named: TREMFYA, SKYRIZI, CIBINQO, DUPIXENT, COSENTYX, Bimzelx, SPEVIGO, NEMLUVIO.
Industry payments across MD — which companies pay providers there.
